- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable in Australia
Total 229 results
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, Canada, Australia, Puerto Rico
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsBelgium, Netherlands, Germany, Italy, United Kingdom, Austria, Czech Republic, Croatia, Turkey, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Medical University of GrazCompletedMyelodysplastic Syndromes | Pulmonary Hypertension | Myeloproliferative DisorderAustria
-
Ellipses PharmaRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia, Netherlands, United Kingdom
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasms (MPNs)United States, Spain, Korea, Republic of, France, Taiwan, Australia, Belgium, Singapore, Israel, Canada, Germany, Finland
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Kirby InstituteCelgeneActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Clinical Hub for Interventional Research (CHOIR)The University of New South Wales; Australian National UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
CelgeneRecruitingBeta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisUnited States, Japan, Israel, United Kingdom, Turkey, Greece, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon, Netherlands
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
The Canadian Blood and Marrow Transplant GroupNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Graft Versus Host Disease | Secondary MyelofibrosisAustralia, Canada, United States, New Zealand, Saudi Arabia
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes | Bone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Preleukemia | Chronic Myelomonocytic LeukemiaUnited States, France, Australia, Netherlands, Spain, Germany, United Kingdom, Finland
-
Eli Lilly and CompanyActive, not recruitingNeoplasms, HematologicUnited States, Germany, Australia, Sweden, France, Spain, Italy, Austria, Canada
-
TetraLogic PharmaceuticalsTerminatedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States, Spain, Australia, Germany
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeAustralia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Secondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Mucositis | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous... and other conditionsUnited States, Canada, Australia
-
CelgeneCompletedLeukemia, Myelomonocytic, Juvenile | Myelodysplastic SyndromeSpain, Germany, Italy, United Kingdom, Belgium, France, Denmark, Netherlands, Sweden, Switzerland, Austria, Czechia, Ireland
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustria, Croatia
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess BlastsUnited States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Down Syndrome | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myeloid Leukemia Associated With Down SyndromeUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicChina, Czechia, Japan, Saudi Arabia, Taiwan, Turkey, Germany, Spain, Netherlands, Italy, Singapore, Australia, Austria, France, United Kingdom, Korea, Republic of, Thailand, Israel, Belgium, Canada, Switzerland, Lithuania, Russian Federation and more
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeSpain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
Astex Pharmaceuticals, Inc.Enrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Spain, Canada, Austria, Slovakia, Bulgaria, Hungary
-
Incyte CorporationRecruitingMyeloproliferative NeoplasmsSpain, Japan, France, Italy, Germany, Australia, United Kingdom, Denmark, Canada
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedJuvenile Myelomonocytic LeukemiaUnited States, Canada, Australia, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Systemic Mastocytosis | DermatofibrosarcomaAustralia
-
medac GmbHSyneos Health; CelerionCompletedMyelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukaemias (ALL) | Acute Myeloid Leukaemias (AML) | Juvenile Myelomonocytic Leukaemias (JMML)Germany, United Kingdom, Italy, Austria, Czechia, Poland
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis PharmaceuticalsUnknownChronic Myeloid LeukaemiaAustralia
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaBelgium, Hungary, Spain, Germany, Canada, Switzerland, Thailand, Korea, Republic of, United Kingdom, Italy, Austria, Sweden, France, United States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia
-
Incyte CorporationActive, not recruitingMPN (Myeloproliferative Neoplasms)United States, France, United Kingdom, Spain, Canada, Japan, Germany, Switzerland, Belgium, Austria, Italy
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Canada, Spain, Hungary, Austria, Czechia, France, Germany, Italy, United Kingdom
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia